Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Cash from Investing Activities (2020 - 2025)

Caribou Biosciences has reported Cash from Investing Activities over the past 6 years, most recently at $18.0 million for Q4 2025.

  • Quarterly Cash from Investing Activities rose 12.81% to $18.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $102.2 million through Dec 2025, up 18.05% year-over-year, with the annual reading at $102.2 million for FY2025, 18.05% up from the prior year.
  • Cash from Investing Activities was $18.0 million for Q4 2025 at Caribou Biosciences, up from $10.9 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $49.4 million in Q1 2025 and troughed at -$174.0 million in Q4 2021.
  • The 5-year median for Cash from Investing Activities is $6.0 million (2022), against an average of -$7.4 million.
  • Year-over-year, Cash from Investing Activities crashed 327659.09% in 2022 and then skyrocketed 179.18% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$174.0 million in 2021, then skyrocketed by 100.67% to $1.2 million in 2022, then tumbled by 2790.09% to -$31.5 million in 2023, then skyrocketed by 150.61% to $15.9 million in 2024, then grew by 12.81% to $18.0 million in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Cash from Investing Activities are $18.0 million (Q4 2025), $10.9 million (Q3 2025), and $24.0 million (Q2 2025).